Advertisement
Original Research Article| Volume 224, ISSUE 6, P1455-1459, December 2022

Fibrinolysis resistance after liver transplant as a predictor of early infection

  • Ivan E. Rodriguez
    Correspondence
    Corresponding author. 12631 E 17th Ave C302, Aurora, CO, 80045.
    Affiliations
    Colorado Center for Transplantation Care, Research, and Education (CCTCARE). Department of Surgery, University of Colorado Anschutz Medical Campus, 1635 Aurora Court, C-318, Aurora, CO, 80045, USA
    Search for articles by this author
  • Dor Yoeli
    Affiliations
    Colorado Center for Transplantation Care, Research, and Education (CCTCARE). Department of Surgery, University of Colorado Anschutz Medical Campus, 1635 Aurora Court, C-318, Aurora, CO, 80045, USA
    Search for articles by this author
  • Tanner Ferrell
    Affiliations
    Colorado Center for Transplantation Care, Research, and Education (CCTCARE). Department of Surgery, University of Colorado Anschutz Medical Campus, 1635 Aurora Court, C-318, Aurora, CO, 80045, USA
    Search for articles by this author
  • Jessie G. Jiang
    Affiliations
    University of Colorado School of Medicine, CU Anschutz Fitzsimons Building, 13001 East 17th Place, C290, Aurora, CO, 80045, USA
    Search for articles by this author
  • Ronald Truong
    Affiliations
    University of Colorado School of Medicine, CU Anschutz Fitzsimons Building, 13001 East 17th Place, C290, Aurora, CO, 80045, USA
    Search for articles by this author
  • Trevor L. Nydam
    Affiliations
    Colorado Center for Transplantation Care, Research, and Education (CCTCARE). Department of Surgery, University of Colorado Anschutz Medical Campus, 1635 Aurora Court, C-318, Aurora, CO, 80045, USA
    Search for articles by this author
  • Megan A. Adams
    Affiliations
    Department of Surgery, Division of Transplant Surgery, Children's Hospital Colorado, 13123 East 16th Avenue, Aurora, CO, 80045, USA
    Search for articles by this author
  • J. Michael Cullen
    Affiliations
    Colorado Center for Transplantation Care, Research, and Education (CCTCARE). Department of Surgery, University of Colorado Anschutz Medical Campus, 1635 Aurora Court, C-318, Aurora, CO, 80045, USA
    Search for articles by this author
  • Elizabeth A. Pomfret
    Affiliations
    Colorado Center for Transplantation Care, Research, and Education (CCTCARE). Department of Surgery, University of Colorado Anschutz Medical Campus, 1635 Aurora Court, C-318, Aurora, CO, 80045, USA
    Search for articles by this author
  • Hunter B. Moore
    Affiliations
    Colorado Center for Transplantation Care, Research, and Education (CCTCARE). Department of Surgery, University of Colorado Anschutz Medical Campus, 1635 Aurora Court, C-318, Aurora, CO, 80045, USA
    Search for articles by this author
Published:September 13, 2022DOI:https://doi.org/10.1016/j.amjsurg.2022.09.011

      Highlights

      • Single-center prospective study with 180 liver transplant recipients.
      • Thrombelastography (TEG) with exogenous tPA used to quantify fibrinolysis activity.
      • Serial TEGs performed on postoperative days 1 and 5.
      • Fibrinolysis resistance is linked to an increased risk of posttransplant infection.

      Abstract

      Background

      Infection is a leading cause of morbidity in liver transplant (LT). Considering that the fibrinolytic system is altered in sepsis, we investigated the relationship between fibrinolysis resistance (FR) and post-transplant infection.

      Methods

      Fibrinolysis was quantified using thrombelastography (TEG) with the addition of tPA to quantify FR. FR was defined as LY30 = 0% and stratified as transient if present on POD1 or POD5 (tFR), persistent (pFR) if present on both, or no FR (nFR) if absent.

      Results

      180 LT recipients were prospectively enrolled. 52 (29%) recipients developed infection. 72 had tFR; 37 had pFR; and 71 had nFR. Recipients with pFR had significantly greater incidence of infections (51% vs. 26% tFR vs. 20% nFR, p = 0.002). pFR was independently associated with increased odds of post-transplant infection (adjusted OR 3.39, p = 0.009).

      Conclusions

      Persistent fibrinolysis resistance is associated with increased risk of post-transplant infection.

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to The American Journal of Surgery
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Nanchal R.S.
        • Ahmad S.
        Infections in liver disease.
        Crit Care Clin. 2016; 32: 411-424
        • Weiss E.
        • Dahmani S.
        • Bert F.
        • et al.
        Early-onset pneumonia after liver transplantation: microbiological findings and therapeutic consequences.
        Liver Transplant. 2010; 16: 1178-1185
        • Amjad W.
        • Qureshi W.
        • Malik A.
        • et al.
        The outcomes of Clostridioides difficile infection in inpatient liver transplant population.
        Transpl Infect Dis. 2022; 24e13750
        • Heldman M.R.
        • Ngo S.
        • Dorschner P.B.
        • et al.
        Pre- and post-transplant bacterial infections in liver transplant recipients.
        Transpl Infect Dis. 2019; 21e13152
        • Kim S.I.
        Bacterial infection after liver transplantation.
        World J Gastroenterol. 2014; 20: 6211-6220
        • Sun H.Y.
        • Cacciarelli T.V.
        • Singh N.
        Impact of pretransplant infections on clinical outcomes of liver transplant recipients.
        Liver Transplant. 2010; 16: 222-228
        • Almeida R.A.
        • Hasimoto C.N.
        • Kim A.
        • et al.
        Antibiotic prophylaxis for surgical site infection in people undergoing liver transplantation.
        Cochrane Database Syst Rev. 2015; 2015Cd010164
        • Mu J.
        • Chen Q.
        • Zhu L.
        • et al.
        Influence of gut microbiota and intestinal barrier on enterogenic infection after liver transplantation.
        Curr Med Res Opin. 2019; 35: 241-248
        • Bhutiani N.
        • Jones C.M.
        • Cannon R.M.
        • et al.
        Assessing relative cost of complications following orthotopic liver transplant.
        Clin Transplant. 2018; 32e13209
        • Bertacco A.
        • Barbieri S.
        • Guastalla G.
        • et al.
        Risk factors for early mortality in liver transplant patients.
        Transplant Proc. 2019; 51: 179-183
        • Moore E.E.
        • Moore H.B.
        • Kornblith L.Z.
        • et al.
        Trauma-induced coagulopathy.
        Nat Rev Dis Prim. 2021; 7: 30
        • Gonzalez E.
        • Moore E.E.
        • Moore H.B.
        • et al.
        Goal-directed hemostatic resuscitation of trauma-induced coagulopathy: a pragmatic randomized clinical trial comparing a viscoelastic assay to conventional coagulation assays.
        Ann Surg. 2016; 263: 1051-1059
        • Semeraro F.
        • Colucci M.
        • Caironi P.
        • et al.
        Platelet drop and fibrinolytic shutdown in patients with sepsis.
        Crit Care Med. 2018; 46: e221-e228
        • Dow N.
        • Coleman J.R.
        • Moore H.
        • et al.
        Dense and dangerous: the tissue plasminogen activator-resistant fibrinolysis shutdown phenotype is due to abnormal fibrin polymerization.
        J Trauma Acute Care Surg. 2020; 88: 258-265
        • Coleman J.R.
        • Kay A.B.
        • Moore E.E.
        • et al.
        It's sooner than you think: blunt solid organ injury patients are already hypercoagulable upon hospital admission - results of a bi-institutional, prospective study.
        Am J Surg. 2019; 218: 1065-1073
        • Prakash S.
        • Verghese S.
        • Roxby D.
        • et al.
        Changes in fibrinolysis and severity of organ failure in sepsis: a prospective observational study using point-of-care test--ROTEM.
        J Crit Care. 2015; 30: 264-270
        • Levi M.
        • van der Poll T.
        Coagulation and sepsis.
        Thromb Res. 2017; 149: 38-44
        • Kang S.
        • Tanaka T.
        • Inoue H.
        • et al.
        IL-6 trans-signaling induces plasminogen activator inhibitor-1 from vascular endothelial cells in cytokine release syndrome.
        Proc Natl Acad Sci U S A. 2020; 117: 22351-22356
        • Moore H.B.
        • Moore E.E.
        • Neal M.D.
        • et al.
        Fibrinolysis shutdown in trauma: historical Review and clinical implications.
        Anesth Analg. 2019; 129: 762-773
        • Moore H.B.
        • Moore E.E.
        • Chapman M.P.
        • et al.
        Viscoelastic measurements of platelet function, not fibrinogen function, predicts sensitivity to tissue-type plasminogen activator in trauma patients.
        J Thromb Haemostasis. 2015; 13: 1878-1887
        • Infanger L.
        • Dibiasi C.
        • Schaden E.
        • et al.
        Comparison of the new viscoelastic coagulation analyzer ClotPro(R) with ROTEM(R) delta and conventional coagulation tests in critically ill patients with COVID-19.
        Front Med. 2021; 8777145
        • Gando S.
        Role of fibrinolysis in sepsis.
        Semin Thromb Hemost. 2013; 39: 392-399
        • Colucci M.
        • Paramo J.A.
        • Collen D.
        Generation in plasma of a fast-acting inhibitor of plasminogen activator in response to endotoxin stimulation.
        J Clin Invest. 1985; 75: 818-824
        • Lorente L.
        • Martín M.M.
        • Borreguero-León J.M.
        • et al.
        Sustained high plasma plasminogen activator inhibitor-1 levels are associated with severity and mortality in septic patients.
        Thromb Res. 2014; 134: 182-186
        • Moore H.B.
        • Moore E.E.
        • Huebner B.R.
        • et al.
        Fibrinolysis shutdown is associated with a fivefold increase in mortality in trauma patients lacking hypersensitivity to tissue plasminogen activator.
        J Trauma Acute Care Surg. 2017; 83: 1014-1022
        • Nicolau-Raducu R.
        • Beduschi T.
        • Vianna R.
        • et al.
        Fibrinolysis shutdown is associated with thrombotic and hemorrhagic complications and poorer outcomes after liver transplantation.
        Liver Transplant. 2019; 25: 380-387
        • Meizoso J.P.
        • Karcutskie C.A.
        • Ray J.J.
        • et al.
        Persistent fibrinolysis shutdown is associated with increased mortality in severely injured trauma patients.
        J Am Coll Surg. 2017; 224: 575-582
        • Roberts D.J.
        • Kalkwarf K.J.
        • Moore H.B.
        • et al.
        Time course and outcomes associated with transient versus persistent fibrinolytic phenotypes after injury: a nested, prospective, multicenter cohort study.
        J Trauma Acute Care Surg. 2019; 86: 206-213
        • Leeper C.M.
        • Neal M.D.
        • McKenna C.J.
        • et al.
        Trending fibrinolytic dysregulation: fibrinolysis shutdown in the days after injury is associated with poor outcome in severely injured children.
        Ann Surg. 2017; 266: 508-515
        • Fricker Z.P.
        • Mukthinuthalapati V.
        • Akinyeye S.
        • et al.
        MELD-Na is more strongly associated with risk of infection and outcomes than other characteristics of patients with cirrhosis.
        Dig Dis Sci. 2021; 66: 247-256
        • Moon H.H.
        • Son H.S.
        • Shafqat M.
        • et al.
        Clinical course of renal disease in recipients of liver transplant who required peritransplant dialysis.
        Transplant Proc. 2019; 51: 2771-2774
        • Dobner J.
        • Kaser S.
        Body mass index and the risk of infection - from underweight to obesity.
        Clin Microbiol Infect. 2018; 24: 24-28
        • Samuels J.
        • Lawson P.J.
        • Morton A.P.
        • et al.
        Prospective assessment of fibrinolysis in morbid obesity: tissue plasminogen activator resistance improves after bariatric surgery.
        Surg Obes Relat Dis. 2019; 15: 1153-1159
        • Kanji R.
        • Gue Y.X.
        • Memtsas V.
        • et al.
        Fibrinolysis in platelet thrombi.
        Int J Mol Sci. 2021; 22
        • Koupenova M.
        • Clancy L.
        • Corkrey H.A.
        • et al.
        Circulating platelets as mediators of immunity, inflammation, and thrombosis.
        Circ Res. 2018; 122: 337-351
        • Mira J.C.
        • Brakenridge S.C.
        • Moldawer L.L.
        • et al.
        Persistent inflammation, immunosuppression and catabolism syndrome.
        Crit Care Clin. 2017; 33: 245-258
        • Keragala C.B.
        • Medcalf R.L.
        Plasminogen: an enigmatic zymogen.
        Blood. 2021; 137: 2881-2889
        • Barrett C.D.
        • Moore H.B.
        • Kong Y.W.
        • et al.
        Tranexamic acid mediates proinflammatory and anti-inflammatory signaling via complement C5a regulation in a plasminogen activator-dependent manner.
        J Trauma Acute Care Surg. 2019; 86: 101-107
        • Loef E.J.
        • Sheppard H.M.
        • Birch N.P.
        • et al.
        Plasminogen and plasmin can bind to human T cells and generate truncated CCL21 that increases dendritic cell chemotactic responses.
        J Biol Chem. 2022; 298102112
        • Heilmann E.
        • Gregoriano C.
        • Schuetz P.
        Biomarkers of infection: are they useful in the ICU?.
        Semin Respir Crit Care Med. 2019; 40: 465-475
        • Perrakis A.
        • Stirkat F.
        • Croner R.S.
        • et al.
        Prognostic and diagnostic value of procalcitonin in the post-transplant setting after liver transplantation.
        Arch Med Sci. 2016; 12: 372-379
        • Sterling S.A.
        • Miller W.R.
        • Pryor J.
        • et al.
        The impact of timing of antibiotics on outcomes in severe sepsis and septic shock: a systematic Review and meta-analysis.
        Crit Care Med. 2015; 43: 1907-1915
        • Pedersen M.
        • Seetharam A.
        Infections after orthotopic liver transplantation.
        J Clin Exp Hepatol. 2014; 4: 347-360
        • Kawada P.S.
        • Bruce A.
        • Massicotte P.
        • et al.
        Coagulopathy in children with liver disease.
        J Pediatr Gastroenterol Nutr. 2017; 65: 603-607